Figure 4 from Clonal Hematopoiesis of Indeterminate Potential and Its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors

CHIP and adverse events. A, Percentage of patients on each treatment that had an adverse event on therapy, split by cohort and treatment. B, Proportions of patients with adverse events split by CHIP status. Lighter shades indicate no adverse event, and darker shades indicate an adverse event. P values were determined by Fisher exact tests.